Skip to content

Clinical trials

Completed Phase 2 Squamous Cell Carcinoma of Head and Neck trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 2 Status: Completed Clear all

241 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20015
20025
20036
20049
200513
200610
200711
20088
20098
20106
20117
201211
201311
201411
20157
201610
201716
20186
201914
202011
202113
202210
20234
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed241

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)22
Groupe Oncologie Radiotherapie Tete et Cou7
M.D. Anderson Cancer Center7
Memorial Sloan Kettering Cancer Center6
Radiation Therapy Oncology Group6
University of Chicago6
Eastern Cooperative Oncology Group5
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5
UNC Lineberger Comprehensive Cancer Center5
University of Michigan Rogel Cancer Center5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck241
Head and Neck Neoplasms114
Salivary Gland Neoplasms25
Carcinoma, Squamous Cell24
Tongue Neoplasms17
Carcinoma, Non-Small-Cell Lung13
Recurrence10
Neoplasm Metastasis8
Neoplasms8
Esthesioneuroblastoma, Olfactory7

Trials

Showing 1 to 25 of 241. Each trial links to its page on Pharma Observatory.

141 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.